METABOLIC & GLP-1

Semaglutide

GLP-1 receptor agonist research peptide. Glucose and metabolic-pathway investigation.

Dose
30 mg / vial
Form
Lyophilized powder
Purity
>99% HPLC-verified
Origin
U.S. synthesis
PRICE $ TBD
Synthesized in U.S.A. HPLC-verified PharmaGrade

ABOUT THIS COMPOUND

Semaglutide 30 MG.

Semaglutide is a synthetic GLP-1 receptor agonist research peptide. It is structurally analogous to native human GLP-1 (7-37) and engineered for extended half-life through albumin binding.

Widely studied in metabolic and glucose-pathway research, Semaglutide is one of the most-investigated GLP-1 agonists in the literature. Synthesized in our U.S. facility, HPLC-verified, and lyophilized under inert atmosphere.

SPECIFICATIONS

Molecule. Method. Documentation.

Compound Data

Molecular weight
~4,114 Da
Sequence length
31 amino acids
Form
Lyophilized powder
Purity (HPLC)
>99%
Solubility
Reconstitute with bacteriostatic water for research
Storage
Long-term at -20°C; sealed, dark, dry

Storage & Handling

Storage temperature
-20°C long-term
Shelf life (sealed)
24 months
Reconstituted shelf life
30 days at 2–8°C
Reconstitution
Bacteriostatic water (research use)
Documentation
Lot-specific COA on request

RESEARCH APPLICATIONS

What researchers study.

All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.

  • GLP-1 pathway pharmacology
  • Glucose-homeostasis research
  • Comparative receptor-agonism studies

QUALITY ASSURANCE

Every vial, the same standard.

U.S. Made Molecule built on American soil
>99% HPLC-verified purity
Lot-Tested COA available on request
PharmaGrade Pharmaceutical-grade synthesis

A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →

YOU MAY ALSO RESEARCH

Related compounds.

QUESTIONS?

Talk to a human.

Lot questions, COA requests, institutional accounts, reach the team directly.

CONTACT US